|
FAM126B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.22920007505911E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.91690013756829E-10 |
| Normal-vs-Stage2 |
3.96900000000366E-05 |
| Normal-vs-Stage3 |
2.94340000150939E-08 |
| Normal-vs-Stage4 |
1.033500000025E-06 |
| Stage1-vs-Stage2 |
7.922600E-01 |
| Stage1-vs-Stage3 |
3.290600E-01 |
| Stage1-vs-Stage4 |
3.257600E-01 |
| Stage2-vs-Stage3 |
3.313600E-01 |
| Stage2-vs-Stage4 |
2.816000E-01 |
| Stage3-vs-Stage4 |
7.269800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33809646591021E-11 |
| Normal-vs-AfricanAmerican |
2.61459999983948E-07 |
| Normal-vs-Asian |
2.459700E-03 |
| Caucasian-vs-AfricanAmerican |
3.046000E-01 |
| Caucasian-vs-Asian |
7.528600E-01 |
| AfricanAmerican-vs-Asian |
9.587600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.72060185280543E-11 |
| Normal-vs-Female |
1.17220000039886E-07 |
| Male-vs-Female |
1.258400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.16339995601822E-10 |
| Normal-vs-Extreme_Weight |
2.59836596683272E-12 |
| Normal-vs-Obese |
1.04499999986629E-07 |
| Normal-vs-Extreme_Obese |
1.834820E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.748200E-01 |
| Normal_Weight-vs-Obese |
1.411830E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.356550E-01 |
| Extreme_Weight-vs-Obese |
7.146300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.293610E-01 |
| Obese-vs-Extreme_Obese |
2.608600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.04140000004127E-06 |
| Normal-vs-Age(41-60Yrs) |
2.49160000409532E-08 |
| Normal-vs-Age(61-80Yrs) |
1.5508039297174E-11 |
| Normal-vs-Age(81-100Yrs) |
2.240900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.717000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.751600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.795400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.835500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.367400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.056800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.10800307501813E-11 |
| Normal-VS-Type2 PRCC |
1.25140009465952E-10 |
| Normal-VS-KIRP CIMP |
3.12770000010509E-07 |
| Normal-VS-Unclassified PRCC |
1.321190E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.312000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.971500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.200000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.025600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.620000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.298400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.61901611509074E-13 |
| Normal-vs-N1 |
4.98599999954052E-07 |
| Normal-vs-N2 |
4.27499999999803E-05 |
| N0-vs-N1 |
4.859800E-01 |
| N0-vs-N2 |
4.042200E-01 |
| N1-vs-N2 |
3.839400E-01 |
|
|
